Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

ANAPTYSBIO, INC (ANAB)

Lizzul Paul F. — Chief Medical Officer
Jan 7, 2026
Sale
Shares
2,235
Price
$45.11
Total Value
$100.82K
Shares Held After
37,213
% of Holdings
5.7%

ANAPTYSBIO, INC (ANAB)

LOUMEAU ERIC J — CHIEF LEGAL OFFICER
Jan 7, 2026
Sale
Shares
500
Price
$47.23
Total Value
$23.61K
Shares Held After
9,157
% of Holdings
5.2%

ANAPTYSBIO, INC (ANAB)

LOUMEAU ERIC J — CHIEF LEGAL OFFICER
Jan 7, 2026
Sale
Shares
1,841
Price
$46.13
Total Value
$84.93K
Shares Held After
9,657
% of Holdings
16.0%

ANAPTYSBIO, INC (ANAB)

LOUMEAU ERIC J — CHIEF LEGAL OFFICER
Jan 7, 2026
Sale
Shares
5,281
Price
$45.38
Total Value
$239.67K
Shares Held After
11,498
% of Holdings
31.5%

ANAPTYSBIO, INC (ANAB)

LOUMEAU ERIC J — CHIEF LEGAL OFFICER
Jan 7, 2026
Sale
Shares
2,017
Price
$45.11
Total Value
$90.99K
Shares Held After
16,779
% of Holdings
10.7%
Jan 7, 2026
Sale
Shares
26,920
Price
$39.11
Total Value
$1.05M
Shares Held After
0
% of Holdings
100.0%

INSMED Inc (INSM)

Smith Michael Alexander — Chief Legal Officer
Jan 7, 2026
Sale
Shares
709
Price
$175.07
Total Value
$124.12K
Shares Held After
58,090
% of Holdings
1.2%

PTC THERAPEUTICS, INC. (PTCT)

Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Jan 7, 2026
Sale
Shares
52
Price
$77.48
Total Value
$4.03K
Shares Held After
6,850
% of Holdings
0.8%

PTC THERAPEUTICS, INC. (PTCT)

Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Jan 7, 2026
Sale
Shares
1,026
Price
$77.48
Total Value
$79.49K
Shares Held After
116,077
% of Holdings
0.9%
Jan 7, 2026
Sale
Shares
11
Price
$78.98
Total Value
$868.78
Shares Held After
117,659
% of Holdings
0.0%
Jan 7, 2026
Sale
Shares
269
Price
$77.92
Total Value
$20.96K
Shares Held After
117,670
% of Holdings
0.2%
Jan 7, 2026
Sale
Shares
471
Price
$77.10
Total Value
$36.31K
Shares Held After
117,939
% of Holdings
0.4%
Jan 7, 2026
Sale
Shares
38
Price
$78.60
Total Value
$2.99K
Shares Held After
117,659
% of Holdings
0.0%
Jan 7, 2026
Sale
Shares
949
Price
$77.91
Total Value
$73.94K
Shares Held After
117,697
% of Holdings
0.8%
Jan 7, 2026
Sale
Shares
1,638
Price
$77.11
Total Value
$126.31K
Shares Held After
118,646
% of Holdings
1.4%
Jan 7, 2026
Sale
Shares
1,503
Price
$77.48
Total Value
$116.45K
Shares Held After
117,659
% of Holdings
1.3%

INSMED Inc (INSM)

Lewis William — Director
Jan 7, 2026
Sale
Shares
2,357
Price
$175.07
Total Value
$412.64K
Shares Held After
318,630
% of Holdings
0.7%

PTC THERAPEUTICS, INC. (PTCT)

Golden Lee Scott — EVP & CHIEF MEDICAL OFFICER
Jan 7, 2026
Sale
Shares
642
Price
$77.48
Total Value
$49.74K
Shares Held After
93,294
% of Holdings
0.7%
Jan 7, 2026
Sale
Shares
3,016
Price
$77.48
Total Value
$233.68K
Shares Held After
396,967
% of Holdings
0.8%

PTC THERAPEUTICS, INC. (PTCT)

Pauwels Eric — CHIEF BUSINESS OFFICER
Jan 7, 2026
Sale
Shares
1,352
Price
$77.48
Total Value
$104.75K
Shares Held After
87,489
% of Holdings
1.5%

PTC THERAPEUTICS, INC. (PTCT)

Utter Christine Marie — SVP, CHIEF ACCOUNTING OFFICER
Jan 7, 2026
Sale
Shares
1,235
Price
$77.45
Total Value
$95.65K
Shares Held After
73,727
% of Holdings
1.6%

INSMED Inc (INSM)

Flammer Martina M.D. — Chief Medical Officer
Jan 7, 2026
Sale
Shares
1,434
Price
$175.84
Total Value
$252.15K
Shares Held After
91,705
% of Holdings
1.5%

INSMED Inc (INSM)

Bonstein Sara — Chief Financial Officer
Jan 7, 2026
Sale
Shares
1,678
Price
$175.07
Total Value
$293.77K
Shares Held After
81,953
% of Holdings
2.0%

INSMED Inc (INSM)

Adsett Roger — Chief Operating Officer
Jan 7, 2026
Sale
Shares
802
Price
$175.07
Total Value
$140.41K
Shares Held After
109,660
% of Holdings
0.7%
Jan 7, 2026
Purchase
Shares
50,000
Price
$16.38
Total Value
$819.00K
Shares Held After
316,155
% of Holdings
15.8%

Apogee Therapeutics, Inc. (APGE)

Dambkowski Carl — Chief Medical Officer
Jan 7, 2026
Sale
Shares
100
Price
$80.06
Total Value
$8.01K
Shares Held After
212,523
% of Holdings
0.0%

Apogee Therapeutics, Inc. (APGE)

Dambkowski Carl — Chief Medical Officer
Jan 7, 2026
Sale
Shares
826
Price
$79.04
Total Value
$65.29K
Shares Held After
212,623
% of Holdings
0.4%

Apogee Therapeutics, Inc. (APGE)

Dambkowski Carl — Chief Medical Officer
Jan 7, 2026
Sale
Shares
14,820
Price
$77.90
Total Value
$1.15M
Shares Held After
213,449
% of Holdings
6.5%

Apogee Therapeutics, Inc. (APGE)

Dambkowski Carl — Chief Medical Officer
Jan 7, 2026
Sale
Shares
2,954
Price
$77.13
Total Value
$227.84K
Shares Held After
228,269
% of Holdings
1.3%

BeOne Medicines Ltd. (ONC)

Lee Chan Henry — SVP, General Counsel
Jan 7, 2026
Sale
Shares
664
Price
$331.76
Total Value
$220.29K
Shares Held After
0
% of Holdings
100.0%
Jan 7, 2026
Sale
Shares
8,576
Price
$72.23
Total Value
$619.44K
Shares Held After
283,394
% of Holdings
2.9%

Avidity Biosciences, Inc. (RNAM)

Calderaro Charles III — Chief Technical Officer
Jan 7, 2026
Sale
Shares
3,727
Price
$72.23
Total Value
$269.20K
Shares Held After
49,797
% of Holdings
7.0%

Avidity Biosciences, Inc. (RNAM)

McCarthy Teresa — Chief Human Resources Officer
Jan 7, 2026
Sale
Shares
1,965
Price
$72.23
Total Value
$141.93K
Shares Held After
116,867
% of Holdings
1.7%

Avidity Biosciences, Inc. (RNAM)

Moriarty John B — Chief Legal Officer
Jan 7, 2026
Sale
Shares
2,374
Price
$72.23
Total Value
$171.47K
Shares Held After
74,557
% of Holdings
3.1%

Avidity Biosciences, Inc. (RNAM)

MacLean Michael F — Chief Financial Officer
Jan 7, 2026
Sale
Shares
1,974
Price
$72.23
Total Value
$142.58K
Shares Held After
63,832
% of Holdings
3.0%

Avidity Biosciences, Inc. (RNAM)

Hughes Steven George — Chief Medical Officer
Jan 7, 2026
Sale
Shares
2,373
Price
$72.23
Total Value
$171.40K
Shares Held After
36,494
% of Holdings
6.1%

Avidity Biosciences, Inc. (RNAM)

Flanagan W. Michael — Chief Scientific Officer
Jan 7, 2026
Sale
Shares
2,373
Price
$72.23
Total Value
$171.40K
Shares Held After
91,627
% of Holdings
2.5%

IONIS PHARMACEUTICALS INC (IONS)

Devers Shannon L. — EVP, Chief Human Resources Ofc
Jan 7, 2026
Sale
Shares
9,264
Price
$84.62
Total Value
$783.92K
Shares Held After
17,494
% of Holdings
34.6%

IONIS PHARMACEUTICALS INC (IONS)

Devers Shannon L. — EVP, Chief Human Resources Ofc
Jan 7, 2026
Sale
Shares
3,829
Price
$84.62
Total Value
$324.01K
Shares Held After
17,494
% of Holdings
18.0%

IONIS PHARMACEUTICALS INC (IONS)

Devers Shannon L. — EVP, Chief Human Resources Ofc
Jan 7, 2026
Sale
Shares
3,460
Price
$84.62
Total Value
$292.79K
Shares Held After
17,494
% of Holdings
16.5%

IONIS PHARMACEUTICALS INC (IONS)

Devers Shannon L. — EVP, Chief Human Resources Ofc
Jan 7, 2026
Sale
Shares
2,101
Price
$85.36
Total Value
$179.34K
Shares Held After
17,494
% of Holdings
10.7%

IONIS PHARMACEUTICALS INC (IONS)

Devers Shannon L. — EVP, Chief Human Resources Ofc
Jan 7, 2026
Sale
Shares
25,545
Price
$85.36
Total Value
$2.18M
Shares Held After
17,494
% of Holdings
59.4%
Jan 7, 2026
Sale
Shares
500
Price
$2.25
Total Value
$1.12K
Shares Held After
346,721
% of Holdings
0.1%

Maze Therapeutics, Inc. (MAZE)

Bernstein Harold — President, R&D & CMO
Jan 7, 2026
Sale
Shares
25,156
Price
$40.20
Total Value
$1.01M
Shares Held After
0
% of Holdings
100.0%
Jan 7, 2026
Sale
Shares
1,700
Price
$1.99
Total Value
$3.38K
Shares Held After
60,500
% of Holdings
2.7%

Acumen Pharmaceuticals, Inc. (ABOS)

Schacterle Amy — Chief Regulatory Officer
Jan 7, 2026
Sale
Shares
1,097
Price
$1.98
Total Value
$2.18K
Shares Held After
7,703
% of Holdings
12.5%

Revolution Medicines, Inc. (RVMD)

Horn Margaret A — Chief Operating Officer
Jan 7, 2026
Sale
Shares
1,700
Price
$102.90
Total Value
$174.93K
Shares Held After
141,053
% of Holdings
1.2%

Revolution Medicines, Inc. (RVMD)

Horn Margaret A — Chief Operating Officer
Jan 7, 2026
Sale
Shares
20,204
Price
$101.79
Total Value
$2.06M
Shares Held After
142,753
% of Holdings
12.4%

Revolution Medicines, Inc. (RVMD)

Horn Margaret A — Chief Operating Officer
Jan 7, 2026
Sale
Shares
53,096
Price
$100.02
Total Value
$5.31M
Shares Held After
162,957
% of Holdings
24.6%

Revolution Medicines, Inc. (RVMD)

Anders Jack — Chief Financial Officer
Jan 7, 2026
Sale
Shares
10,000
Price
$98.00
Total Value
$980.00K
Shares Held After
108,065
% of Holdings
8.5%
Version: v26.3.33